Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Structure of the first sphingosine 1-phosphate receptor.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.
Prediction of response to interferon therapy in multiple sclerosis.
Effect of Estrogen on Th1, Th2 and Th17 Cytokine Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients.
[Central motor pathways in children with multiple sclerosis].
Bilateral hearing loss as a manifestation of neuromyelitis optica.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Cine cerebrospinal fluid imaging in multiple sclerosis.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Association between parasite infection and immune responses in multiple sclerosis.
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
ACUTE RETINAL NECROSIS AND IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN A NATALIZUMAB-TREATED PATIENT WITH MULTIPLE SCLEROSIS.

Pages